Citigroup (NYSE:C) will release its earnings data before the market opens on Monday, July 15th. Analysts expect Citigroup to post earnings of $1.86 per share for the quarter.

Citigroup (NYSE:C) last announced its quarterly earnings results on Monday, April 15th. The financial services provider reported $1.87 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.78 by $0.09. The firm had revenue of $18.58 billion for the quarter, compared to analyst estimates of $18.56 billion. Citigroup had a net margin of 18.32% and a return on equity of 10.05%. The business’s revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.68 EPS. On average, analysts expect Citigroup to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Shares of Citigroup stock opened at $71.77 on Friday. The company has a market cap of $165.97 billion, a price-to-earnings ratio of 10.79, a PEG ratio of 0.79 and a beta of 1.74. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a fifty day simple moving average of $67.50. Citigroup has a 52-week low of $48.42 and a 52-week high of $75.24.

In related news, CEO Stephen Bird sold 30,000 shares of the company’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $69.33, for a total transaction of $2,079,900.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.09% of the stock is owned by corporate insiders.

Several brokerages have issued reports on C. BMO Capital Markets boosted their price target on shares of Citigroup from $92.00 to $93.00 and gave the company an “outperform” rating in a report on Monday, April 15th. Goldman Sachs Group raised shares of UCB S A/ADR from a “neutral” rating to a “buy” rating in a report on Thursday, May 30th. Oppenheimer set a $15.00 target price on shares of Strongbridge Biopharma and gave the company a “buy” rating in a research note on Tuesday, March 26th. Berenberg Bank downgraded shares of to a “hold” rating and reduced their target price for the company from GBX 283 ($3.70) to GBX 103 ($1.35) in a research note on Monday, June 17th. Finally, Bank of America set a $77.00 target price on shares of Citigroup and gave the company a “buy” rating in a research note on Monday, June 10th. Four analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. Citigroup presently has a consensus rating of “Buy” and a consensus target price of $79.18.

Citigroup Company Profile

Citigroup Inc, a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions in North America, Latin America, Asia, Europe, the Middle East, and Africa. The company operates through two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG).

Recommended Story: Book Value Of Equity Per Share – BVPS Explained

Earnings History for Citigroup (NYSE:C)

Receive News & Ratings for Citigroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citigroup and related companies with's FREE daily email newsletter.